You are here: Industry Insights > COVID-19 vaccine

News List

COVID-19 vaccine market set to reach $19.5bn by 2026 pharmaceutical-technology
July 26, 2021
The size of the COVID-19 vaccine market across the seven major markets – the US, Germany, France, Italy, Spain, the UK, and Japan -will increase from $13.6bn in 2021 to $19.5bn in 2026 at a compound annual growth rate (CAGR) of 7.6% should annual ...
U.S. Govt. Buys Additional 200M Doses of Pfizer-BioNTech COVID Vax contractpharma
July 26, 2021
The U.S. government has purchased an additional 200 million doses of the Pfizer-BioNTech COVID-19 Vaccine, expected to be delivered from October 2021 through April 2022.
TGA approves Pfizer COVID-19 vaccine for 12 to 15-year-olds firstwordpharma
July 23, 2021
Australia’s COVID-19 vaccination rollout has taken another step forward with the Pfizer vaccine being approved for use in children aged 12 to 15 years.
Study shows why second dose of COVID-19 vaccine shouldn't be skipped worldpharmanews
July 22, 2021
The second dose of a COVID-19 vaccine induces a powerful boost to a part of the immune system that provides broad antiviral protection, according to a study led by investigators at the Stanford University School of Medicine.
Takeda expands Covid-19 vaccine supply deal with Moderna pharmaceutical-technology
July 22, 2021
Takeda Pharmaceutical has entered a new agreement with Moderna and the Government of Japan’s Ministry of Health, Labour and Welfare (MHLW) to import and supply 50 million doses of Moderna’s mRNA Covid-19 vaccine in the country.
EU begins real-time review of Sanofi-GSK COVID-19 vaccine expresspharma
July 22, 2021
The decision to start the "rolling review" of the vaccine, Vidprevtyn, was based on preliminary results from lab studies and early-stage clinical trials in adults, the European Medicines Agency (EMA) said.
Pfizer, BioNTech Partner with Biovac for COVID-19 Vax in Africa contractpharma
July 22, 2021
Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network.
PM wants review of AstraZeneca age advice firstwordpharma
July 22, 2021
Australia's expert immunisation panel has been urged to consider expanding the age recommendation for AstraZeneca's COVID-19 vaccine to people aged under 60, as reported This is Money on Wednesday.
‘Marketplace’ launched to speed up global access to COVID-19 vaccine europeanpharmaceuticalreview
July 21, 2021
CEPI has launched COVAX Marketplace to accelerate the global production of COVID-19 vaccines, increasing access to doses.
Centre provides over 42 crore vaccine doses to states and UTs expresspharma
July 20, 2021
Over 2.11 crore balance and unutilised doses still available with states and Union Territories (UTs), and private hospitals.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page